视神经脊髓炎
医学
髓鞘少突胶质细胞糖蛋白
多发性硬化
少突胶质细胞
髓鞘
疾病
光谱紊乱
免疫学
白质
抗体
糖蛋白
病理
中枢神经系统
内科学
遗传学
磁共振成像
放射科
精神科
实验性自身免疫性脑脊髓炎
生物
作者
John H. Rees,Torge Rempe,İbrahim Sacit Tuna,Mayra Montalvo Perero,Shyamsunder Sabat,Tara Massini,Joseph M. Yetto
标识
DOI:10.1016/j.mric.2023.12.001
摘要
For over two centuries, clinicians have been aware of various conditions affecting white matter which had come to be grouped under the umbrella term multiple sclerosis. Within the last 20 years, specific scientific advances have occurred leading to more accurate diagnosis and differentiation of several of these conditions including, neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody disease. This new understanding has been coupled with advances in disease-modifying therapies which must be accurately applied for maximum safety and efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI